STOCK TITAN

Universal Health Realty Income Trust Reports 2020 Second Quarter Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Universal Health Realty Income Trust (NYSE: UHT) reported a net income of $4.7 million, or $0.34 per diluted share, for Q2 2020, an increase from $4.3 million, or $0.31 per diluted share, in Q2 2019. Funds from operations (FFO) rose to $11.4 million, or $0.83 per diluted share, compared to $11.0 million, or $0.80 per share, a year earlier. A $765,000 decrease in interest expense positively impacted results. However, vacancies in two hospital facilities led to a $183,000 net operating loss in Q2 2020. The company declared a dividend of $0.69 per share in June 2020, totaling $9.5 million.

Positive
  • Net income increased to $4.7 million in Q2 2020 from $4.3 million in Q2 2019.
  • FFO rose to $11.4 million in Q2 2020 compared to $11.0 million in Q2 2019.
  • Interest expense decreased by $765,000, enhancing profitability.
Negative
  • Vacancies in two hospital facilities resulted in a $183,000 net operating loss during Q2 2020.
  • The two vacant properties generated a combined net operating loss of approximately $381,000 for the six-month period ended June 30, 2020.

KING OF PRUSSIA, Pa., July 27, 2020 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended June 30, 2020, net income was $4.7 million, or $.34 per diluted share, as compared to $4.3 million, or $.31 per diluted share, during the second quarter of 2019. 

As calculated on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our funds from operations ("FFO"), were $11.4 million, or $.83 per diluted share during the second quarter of 2020, as compared to $11.0 million, or $.80 per diluted share during the second quarter of 2019.

Favorably impacting our net income and FFO during the second quarter of 2020, as compared to the second quarter of 2019, was a decrease in our interest expense of $765,000, or $.06 per diluted share. The decreased interest expense resulted primarily from a decrease in the average cost of borrowings pursuant to our revolving credit agreement, partially offset by an increase in our average outstanding borrowings.  Unfavorably impacting our net income and FFO during the second quarter of 2020, as compared to the second quarter of 2019, were the previously disclosed vacancies that occurred as of June 1, 2019 and September 30, 2019, at two hospital facilities located in Corpus Christi, Texas, and Evansville, Indiana, respectively. These two properties generated a combined net operating loss of $183,000 during the second quarter of 2020, as compared to generating combined net operating income of $512,000 during the second quarter of 2019. See below for additional disclosure regarding these properties.

Consolidated Results of Operations - Six-Month Periods Ended June 30, 2020 and 2019:

For the six-month period ended June 30, 2020, our net income was $9.3 million, or $.67 per diluted share, as compared to $8.5 million, or $.62 per diluted share during the first six months of 2019. As reflected on the attached Supplemental Schedule, our financial results for the six-month period ended June 30, 2019 included a gain of $250,000, or $.02 per diluted share, related to the sale of a parcel of land located at one of our buildings.

As also calculated on the Supplemental Schedule, our FFO were $22.6 million, or $1.64 per diluted share, during the first six months of 2020, as compared to $21.9 million, or $1.60 per diluted share, during the first six months of 2019.

Favorably impacting our net income and FFO during the six months ended June 30, 2020, as compared to the first six months of 2019, was a decrease in our interest expense of approximately $1.1 million, or $.08 per diluted share.  The decrease in interest expense resulted primarily from a decrease in our average cost of borrowings pursuant to our revolving credit agreement, partially offset by an increase in our average outstanding borrowings.  Unfavorably impacting our net income and FFO during the six months ended June 30, 2020, as compared to the first six months of 2019, were the previously disclosed vacancies at two hospital facilities, as mentioned above, that occurred as of June 1, 2019 and September 30, 2019.  These two properties generated a combined net operating loss of approximately $381,000 during the six months ended June 30, 2020, as compared to generating combined net operating income of approximately $873,000 during the six months ended June 30, 2019.

COVID-19

The COVID-19 pandemic began to significantly impact the United States in mid-March, 2020.  As a result of various policies implemented by the federal and state governments, and varying by individual state, many non-essential businesses in the nation were closed for varying time periods. With the exception of the operators of our four preschool and childcare centers, which were closed from mid-March until mid-June, we believe that most of the tenants occupying our hospitals, medical office buildings ("MOBs") and ambulatory care centers were permitted to continue operating if they elected to do so.  

Tenants representing approximately 98% of our occupied square footage have paid their June rent. We believe that as of June 30, 2020, substantially all of our tenants have resumed operations of their businesses. However, many of our properties are located in states that have experienced significant increases in COVID-19 infections in June and July. Such states include Arizona, California, Florida, Georgia, Nevada and Texas.  Although COVID-19 has not had a material adverse impact on our results of operations through June 30, 2020, we believe that the potentially adverse impact that the pandemic may have on our future operations and financial results of our tenants, and in turn ours, will depend upon many factors, most of which are beyond our, or our tenants', ability to control or predict. Since the underlying businesses in each of our properties are operated by the tenants, we can provide no assurance that the businesses will continue to operate in the future, or stay current with their lease obligations. 

Throughout the common areas of many properties in our portfolio, we have implemented COVID-19 risk mitigating actions such as, enhanced cleaning protocols including supplemental cleaning and sanitizing of high-touch points, limiting points of entry at certain facilities, and coordinating with health care providers to assess or screen patients prior to entering certain of our MOBs.

Since the bonus rents earned by us on the three acute care hospitals leased to wholly-owned subsidiaries of Universal Health Services, Inc., are computed based upon a computation that compares each hospital's current quarter revenue to the corresponding quarter in the base year, we could experience significant declines in future bonus rental revenue earned on these properties should those hospitals continue to experience significant declines in patient volumes and revenues. These hospitals believe that, to the extent that they experience revenue declines and increased expenses resulting from the COVID-19 pandemic, as ultimately measured over the life of the pandemic, they are eligible for emergency fund grants as provided for by the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"). Our financial statements for the three and six-month periods ended June 30, 2020 include bonus rental attributable to revenues recorded by these three hospitals in connection with CARES Act grants.       

Dividend Information:

The second quarter dividend of $.69 per share, or $9.5 million in the aggregate, was declared on June 3, 2020 and paid on June 30, 2020.

Capital Resources Information:

On June 5, 2020, we entered into the first amendment to our credit agreement which increased the credit commitment by $50 million, to $350 million. At June 30, 2020, we had $221.3 million of borrowings outstanding pursuant to the terms of this facility and $123.1 million of available borrowing capacity, net of outstanding borrowings and letters of credit. The credit agreement has a scheduled maturity date of March, 2022, however, we have the option to extend the maturity date for up to two additional six-month periods.

At-the-market Equity Issuance Program ("ATM Program"):

During the second quarter of 2020, we commenced an at-the-market equity issuance program pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of $100 million to or through BofA Securities, Inc., Credit Agricole Securities (USA) Inc., Fifth Third Securities, Inc., SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC (collectively, the Agents).  Pursuant to this ATM Program, during the second quarter of 2020, we issued 2,704 shares at an average price of $101.30 per share which generated approximately $270,000 of net cash proceeds (net of compensation to BofA Securities, Inc.).    Additionally, we paid or incurred approximately $435,000 in various fees and expenses related to the commencement of our ATM program. 

Lease Expirations/Vacancies of Two Hospital Facilities:

As previously disclosed, the tenants in two of our hospital facilities had provided notice to us that they did not intend to renew the leases upon the scheduled expiration of the respective facilities. The leases on these two hospital facilities, located in Evansville, Indiana, and Corpus Christi, Texas, expired on May 31, 2019 and June 1, 2019, respectively. Prior to the vacancy of the property on September 30, 2019, the former tenant of the hospital located in Evansville, Indiana, entered into a short-term lease with us, which covered the period of June 1, 2019 through September 30, 2019, at a substantially increased lease rate as compared to the original lease rate.

The combined lease revenue generated at these facilities amounted to approximately $537,000 and $900,000 during the three and six-month periods ended June 30, 2019, respectively. The hospital located in Evansville, Indiana, has remained vacant since September 30, 2019 and the hospital located in Corpus Christi, Texas, has remained vacant since June 1, 2019.  

We continue to market each property for lease to new tenants. However, should these properties continue to remain owned and vacant for an extended period of time, or should we experience decreased lease rates on future leases, as compared to prior/expired lease rates, or incur substantial renovation costs to make the properties suitable for other operators/tenants, our future results of operations could be materially unfavorably impacted.            

New Construction Projects:

Behavioral Health Hospital - Clive, Iowa

In late July, 2019, a wholly-owned subsidiary of ours entered into an agreement to build and lease a newly constructed 108-bed behavioral health care hospital located in Clive, Iowa. The lease on this facility, which is triple net and has an initial term of 20 years with five, 10-year renewal options, was executed with Clive Behavioral Health, LLC, a joint venture between Universal Health Services, Inc. ("UHS") and Catholic Health Initiatives-Iowa, Corp. (d/b/a Mercy One Des Moines Medical Center).

Construction of this hospital, for which we have engaged a wholly-owned subsidiary of UHS to act as project manager, is expected to be completed in late 2020 or early 2021. The hospital lease will commence upon issuance of the certificate of occupancy and the initial annual rent is estimated to be approximately $2.7 million. The approximate cost of the project is estimated to be $37.5 million, approximately $17.4 million of which has been incurred as of June 30, 2020. 

Medical Office Building - Denison, Texas

In September, 2019, we entered into an agreement whereby we will own a 95% ownership interest in Grayson Properties II LP, which will develop, construct, own and operate the Texoma Medical Plaza II, a 75,000 rentable square feet medical office building ("MOB") located in Denison, Texas. This MOB, which is scheduled to be completed in late 2020, will be located on the campus of Texoma Medical Center, a hospital that is owned and operated by a wholly-owned subsidiary of UHS. 

A 10-year master flex lease was executed with the wholly-owned subsidiary of UHS for 40,000 rentable square feet, representing over 50% of the rentable square feet of the MOB.  The master flex lease commitment is subject to reduction upon the execution of third-party leases on up to 20,000 rentable square feet of the first and second floors of the three-story MOB, and 20,000 rentable square feet on the third floor.  In April, 2020, a new, 122-month lease was fully executed with a third-party tenant for approximately 26,000 rentable square feet on the first floor of the MOB.  As a result, the master flex lease commitment was reduced to 20,000 of rentable square feet on the third floor of the MOB.  After giving effect to this new lease, 61% of the rentable square feet of the MOB is under lease agreements.

Effective June 1, 2020, a $13.1 million third-party construction loan was obtained by Grayson Properties II LP, which is scheduled to mature on June 1, 2025 and has an outstanding balance of $7.1 million as of June 30, 2020. In addition, we have committed to invest up to $4.8 million in equity or member loans in the development and construction of this MOB, none of which has been invested as of June 30, 2020.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments in seventy-one properties located in twenty states, including two that are currently under construction.  

This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, those related to the anticipated impact of COVID-19 on our financial results, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk Factors in our Form 10-K for the year ended December 31, 2019 and in Item 2 – Forward-Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter period ended March 31, 2020), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. 

Many of the factors that could affect our future results are beyond our control or ability to predict, including the impact of the COVID-19 pandemic. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by developments related to COVID-19.  Such developments include, but are not limited to, the length of time and severity of the spread of the pandemic; the volume of cancelled or rescheduled elective procedures and the volume of COVID-19 patients treated by the operators of our hospitals and other healthcare facilities; measures our tenants are taking to respond to the COVID-19 pandemic; the impact of government and administrative regulation and stimulus on the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions to clinical staffing and shortages and disruptions related to supplies required for our tenants' employees and patients; and potential increases to expenses incurred by our tenants related to staffing, supply chain or other expenditures.  There may be significant declines in future bonus rental revenue earned on our hospital  properties leased to subsidiaries of UHS to the extent that each hospital continues to experience significant decline in patient volumes. We believe that the underlying businesses operated by certain of our other tenants have been, at various times, either temporarily closed entirely or operating at substantially reduced hours. These factors may result in the inability or unwillingness on the part of some of our tenants to make timely payment of their rent to us at current levels or to seek to amend or terminate their leases which, in turn, would have an adverse effect on our occupancy levels and our revenue and cash flow and the value of our properties, and potentially, our ability to maintain our dividend at current levels. Due to COVID-19 restrictions and its impact on the economy, we may experience a decrease in prospective tenants which could unfavorably impact the volume of new leases, as well as the renewal rate of existing leases. The COVID-19 pandemic may delay our construction projects which could result in increased costs and delay the timing of opening and rental payments from those projects, although no such delays have yet occurred. The COVID-19 pandemic could also impact our indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financing perspective; and changes in general economic conditions nationally and regionally in the markets our properties are located resulting from the COVID-19 pandemic. We are not able to quantify the impact that these factors will have on our financial results during 2020, but developments related to the COVID-19 pandemic could have a material adverse impact on our future financial results.

 We believe that adjusted net income and adjusted net income per diluted share (as reflected on the attached Supplemental Schedules), which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains on transactions.

Funds from operations ("FFO") is a widely recognized measure of performance for Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts ("NAREIT"), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of gains, such as gains on transactions during the periods presented.  To the extent a REIT recognizes a gain or loss with respect to the sale of incidental assets, such as the sale of land peripheral to operating properties, the REIT has the option to exclude or include such gains and losses in the calculation of FFO.  We have opted to exclude gains and losses from sales of incidental assets in our calculation of FFO.  FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2019 and our report on Form 10-Q for the quarterly period ended March 31, 2020. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

 (more)

 

 

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three and Six Months Ended June 30, 2020 and 2019

(amounts in thousands, except share information)

(unaudited)

 



Three Months Ended



Six Months Ended




June 30,



June 30,




2020



2019



2020



2019


Revenues:

















  Lease revenue - UHS facilities (a.)


$

5,981



$

5,651



$

11,862



$

11,444


  Lease revenue- Non-related parties



12,843




13,178




25,685




25,909


  Other revenue - UHS facilities



221




209




435




422


  Other revenue - Non-related parties



236




288




506




663





19,281




19,326




38,488




38,438


Expenses:

















  Depreciation and amortization



6,381




6,426




12,761




13,134


  Advisory fees to UHS



1,027




982




2,043




1,952


  Other operating expenses



5,576




5,330




10,959




10,540





12,984




12,738




25,763




25,626


Income before equity in income of unconsolidated limited liability companies ("LLCs"), interest expense and gain on sale



6,297




6,588




12,725




12,812


  Equity in income of unconsolidated LLCs



419




454




854




884


  Gain on sale of land



-




-




-




250


Interest expense, net



(2,016)




(2,781)




(4,325)




(5,473)


Net income


$

4,700



$

4,261



$

9,254



$

8,473


Basic earnings per share


$

0.34



$

0.31



$

0.67



$

0.62


Diluted earnings per share


$

0.34



$

0.31



$

0.67



$

0.62



















Weighted average number of shares outstanding - Basic



13,739




13,730




13,737




13,729


Weighted average number of shares outstanding - Diluted



13,761




13,749




13,759




13,748



















(a.) Includes bonus rental on UHS hospital facilities of $1,417 and $1,352 for the three-month periods ended June 30, 2020 and 2019, respectively, and $2,797 and $2,746 for the six-month periods ended June 30, 2020 and 2019, respectively.


 

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

For the Three Months Ended June 30, 2020 and 2019

 (amounts in thousands, except share information)

(unaudited)

 

Calculation of Adjusted Net Income

 




Three Months Ended



Three Months Ended




June 30, 2020



June 30, 2019




Amount



Per

Diluted Share



Amount



Per

Diluted Share


Net income


$

4,700



$

0.34



$

4,261



$

0.31


Adjustments:



-




-




-




-


Subtotal adjustments to net income



-




-




-




-


Adjusted net income


$

4,700



$

0.34



$

4,261



$

0.31


 

Calculation of Funds From Operations ("FFO")






Three Months Ended



Three Months Ended




June 30, 2020



June 30, 2019




Amount



Per

Diluted Share



Amount



Per

Diluted Share


Net income


$

4,700



$

0.34



$

4,261



$

0.31


Plus: Depreciation and amortization expense:

















Consolidated investments



6,381




0.47




6,426




0.47


Unconsolidated affiliates



293




0.02




291




0.02


FFO


$

11,374



$

0.83



$

10,978



$

0.80


Dividend paid per share






$

0.690







$

0.680


 

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

For the Six Months Ended June 30, 2020 and 2019

 (amounts in thousands, except share information)

(unaudited)

 

Calculation of Adjusted Net Income

 



Six Months Ended



Six Months Ended




June 30, 2020



June 30, 2019




Amount



Per

Diluted Share



Amount



Per

Diluted Share


Net income


$

9,254



$

0.67



$

8,473



$

0.62


Adjustments:

















Less: Gain on sale of land



-




-




(250)




(0.02)


Subtotal adjustments to net income



-




-




(250)




(0.02)


Adjusted net income


$

9,254



$

0.67



$

8,223



$

0.60


 

Calculation of Funds From Operations ("FFO")






















Six Months Ended



Six Months Ended




June 30, 2020



June 30, 2019




Amount



Per

Diluted Share



Amount



Per

Diluted Share


Net income


$

9,254



$

0.67



$

8,473



$

0.62


Plus: Depreciation and amortization expense:

















Consolidated investments



12,761




0.93




13,134




0.96


Unconsolidated affiliates



579




0.04




574




0.04


Less: Gain on sale of land



-




-




(250)




(0.02)


FFO


$

22,594



$

1.64



$

21,931



$

1.60


Dividend paid per share






$

1.375







$

1.355


 

 

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)

 



June 30,



December 31,




2020



2019











Assets:









Real Estate Investments:









Buildings and improvements and construction in progress


$

586,391



$

572,503


Accumulated depreciation



(205,720)




(194,888)





380,671




377,615


Land



54,892




54,892


               Net Real Estate Investments



435,563




432,507


Investments in limited liability companies ("LLCs")



4,408




6,918


Other Assets:









Cash and cash equivalents



6,342




6,110


Lease and other receivables from UHS



3,023




2,963


Lease receivable - other



7,354




7,640


Intangible assets (net of accumulated amortization of $18.4 million and $26.5 million, respectively)



12,948




14,553


Right-of-use land assets, net



8,929




8,944


Deferred charges and other assets, net



8,039




9,154


               Total Assets


$

486,606



$

488,789


Liabilities:









Line of credit borrowings


$

221,250



$

212,950


Mortgage notes payable, non-recourse to us, net



59,871




60,744


Accrued interest



346




374


Accrued expenses and other liabilities



18,287




12,888


Ground lease liabilities, net



8,929




8,944


Tenant reserves, deposits and deferred and prepaid rents



11,683




11,155


               Total Liabilities



320,366




307,055


Equity:









Preferred shares of beneficial interest $.01 par value; 5,000,000 shares authorized; none issued and outstanding



-




-


Common shares, $.01 par value;  95,000,000 shares authorized; issued and outstanding: 2020 - 13,769,586;    2019 - 13,757,498



138




138


Capital in excess of par value



266,843




266,723


Cumulative net income



670,534




661,280


Cumulative dividends



(766,342)




(747,417)


Accumulated other comprehensive (loss)/income



(4,933)




1,010


     Total Equity



166,240




181,734


               Total Liabilities and Equity


$

486,606



$

488,789


 

 

Cision View original content:http://www.prnewswire.com/news-releases/universal-health-realty-income-trust-reports-2020-second-quarter-financial-results-301100501.html

SOURCE Universal Health Realty Income Trust

FAQ

What was Universal Health Realty Income Trust's net income for Q2 2020?

Universal Health Realty Income Trust reported a net income of $4.7 million, or $0.34 per diluted share, for Q2 2020.

How did the funds from operations (FFO) of UHT perform in Q2 2020?

FFO for UHT in Q2 2020 was $11.4 million, or $0.83 per diluted share, compared to $11.0 million, or $0.80 per diluted share, in Q2 2019.

What factors negatively impacted UHT's net income in Q2 2020?

Vacancies in two hospital facilities led to a combined net operating loss of $183,000 in Q2 2020.

What dividend did UHT declare in June 2020?

UHT declared a second quarter dividend of $0.69 per share, amounting to a total of $9.5 million.

What was the impact of COVID-19 on UHT's operations?

While COVID-19 did not materially impact operations through June 30, 2020, future performance is uncertain due to potential tenant revenue declines.

Universal Health Realty Income Trust

NYSE:UHT

UHT Rankings

UHT Latest News

UHT Stock Data

589.29M
13.85M
8.08%
62.89%
0.67%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States of America
KING OF PRUSSIA